Cite
HARVARD Citation
Taira, N. et al. (2021). Health-Related Quality of Life With Trastuzumab Monotherapy Versus Trastuzumab Plus Standard Chemotherapy as Adjuvant Therapy in Older Patients With HER2-Positive Breast Cancer. Journal of clinical oncology. 39 (22), pp. 2452-2462. [Online].